Harada N - Search Results

1

Absence of Kaposi's sarcoma-associated herpesvirus (KSHV) in bone marrow cells from Japanese myeloma patients.

Harada N, Hata H, Matsuno F, Sonoki T, Kuribayashi N, Matsuzaki H, Mitsuya H. Harada N, et al. Leukemia. 1999 Sep;13(9):1465-6. doi: 10.1038/sj.leu.2401497. Leukemia. 1999. PMID: 10483001 No abstract available.

2

Expression of Bcl-2 family of proteins in fresh myeloma cells.

Harada N, Hata H, Yoshida M, Soniki T, Nagasaki A, Kuribayashi N, Kimura T, Matsuzaki H, Mitsuya H. Harada N, et al. Leukemia. 1998 Nov;12(11):1817-20. doi: 10.1038/sj.leu.2401168. Leukemia. 1998. PMID: 9823959

3

Detection of inducible nitric oxide synthase (iNOS) mRNA by RT-PCR in ATL patients and HTLV-I infected cell lines: clinical features and apoptosis by NOS inhibitor.

Sonoki T, Matsuzaki H, Nagasaki A, Hata H, Yoshida M, Matsuoka M, Kuribayashi N, Kimura T, Harada N, Takatsuki K, Mitsuya H, Mori M. Sonoki T, et al. Among authors: harada n. Leukemia. 1999 May;13(5):713-8. doi: 10.1038/sj.leu.2401398. Leukemia. 1999. PMID: 10374875

4

Hyperdiploid myeloma cell as an indicator of poor prognosis and drug refractoriness.

Hata H, Matsuzaki H, Yoshida M, Sonoki T, Kuribayashi N, Nagasaki A, Kimura T, Harada N, Takatsuki K. Hata H, et al. Among authors: harada n. Int J Hematol. 1997 Aug;66(2):219-26. doi: 10.1016/s0925-5710(97)00033-9. Int J Hematol. 1997. PMID: 9277053

5

Amplification and overexpression of the PRAD1/Cyclin D1 gene in a multiple myeloma cell line.

Sonoki T, Nakazawa N, Hata H, Taniwaki M, Nagasaki A, Seto M, Yoshida M, Kuribayashi N, Kimura T, Harada N, Mitsuya H, Matsuzaki H. Sonoki T, et al. Among authors: harada n. Int J Hematol. 1998 Dec;68(4):459-61. Int J Hematol. 1998. PMID: 9885448 No abstract available.

6

Establishment of a monoclonal antibody to human myeloma cell: relation to chemotherapy and extramedullar infiltration.

Kuribayashi N, Hata H, Matsuzaki H, Yoshida M, Sonoki T, Nagasaki A, Kimura T, Harada N, Takatsuki K. Kuribayashi N, et al. Among authors: harada n. Med Oncol. 1998 Dec;15(4):248-54. doi: 10.1007/BF02787208. Med Oncol. 1998. PMID: 9951688

7

Establishment and characterization of a CD95 (Fas/Apo-1)-negative myeloma cell line.

Kuribayashi N, Hata H, Yoshida M, Sonoki T, Nagasaki A, Kimura T, Harada N, Matsuzaki H. Kuribayashi N, et al. Among authors: harada n. Acta Haematol. 1999;101(3):113-8. doi: 10.1159/000040935. Acta Haematol. 1999. PMID: 10352328

8

Expression of PRAD1/cyclin D1 in plasma cell malignancy: incidence and prognostic aspects.

Sonoki T, Hata H, Kuribayashi N, Yoshida M, Harada N, Nagasaki A, Kimura T, Matsuno F, Mitsuya H, Matsuzaki H. Sonoki T, et al. Among authors: harada n. Br J Haematol. 1999 Mar;104(3):614-7. doi: 10.1046/j.1365-2141.1999.01204.x. Br J Haematol. 1999. PMID: 10086803 Free article.

9

Down-regulation of CD98 in melphalan-resistant myeloma cells with reduced drug uptake.

Harada N, Nagasaki A, Hata H, Matsuzaki H, Matsuno F, Mitsuya H. Harada N, et al. Acta Haematol. 2000;103(3):144-51. doi: 10.1159/000041037. Acta Haematol. 2000. PMID: 10940652

10

Cellular biological differences between human myeloma cell lines KMS-12-PE and KMS-12-BM established from a single patient.

Otsuki T, Hata H, Harada N, Matsuzaki H, Yata K, Wada H, Yawata Y, Ueki A, Yamada O. Otsuki T, et al. Among authors: harada n. Int J Hematol. 2000 Aug;72(2):216-22. Int J Hematol. 2000. PMID: 11039672

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,474 results

Search Page

Filters